Please try another search
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Chih-Hui Lin | 40 | 2010 | Chairperson of the Board |
Yumei Shue | - | 2017 | Director |
De-Quan Fan | 40 | 2015 | Independent Director |
Hui-Lan Chiu | - | 2021 | Director |
Fang-Ping Chen | - | 2017 | Independent Director |
De Ren Liu | - | 2020 | Director |
Te-Chien Chou | - | 2015 | Director |
Xiu-Mei Lin | 41 | 2015 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review